Biomaterials startup Zentraxa announce seed investment

Posted by 

SETsquared Bristol

Our member company and University of Bristol spin-out, Zentraxa, has raised capital investment from Future Planet Capital, BPEC and Science Angel Syndicate to develop their innovative Zentide platform for engineering bespoke biomaterials.

With generous support of their recently awarded Innovate UK grant, Zentraxa is rapidly moving towards contracted commercial concept development in both medical adhesives and personal care. They are partnering with two leading multi-billion-pound corporations in these high-potential and lucrative markets.

Zentraxa’s platform uses advanced scientific engineering to design precision peptide sequences with distinct functional properties that are commercially viable and can easily be integrated with existing systems. This could be in medicine, for example, skin bonding and wound care, or personal use, such as skin and hair.

This investment will further support product development and enable scale-up of their platform technology.

Jonathan Wogel, Executive Chair and Director of Zentraxa, says:

“We are excited to develop our technology in line with the needs of our new commercial partners and deliver innovative material solutions to people as soon as possible. The funding will allow us to move quickly and hit our production milestones effectively.”

Zentraxa’s platform, Zentide, is particularly effective at producing materials that are difficult to make. With proof-of-concept projects in the pipeline, and commercial scale development lined up behind them, Zentraxa aims to lead the charge in producing scalable, sustainable by design, innovative biomaterials to improve performance in everyday products.

Hassan Mahmudul, Associate at UK Innovation & Science Seed Fund, Future Planet Capital, says:

 “We are delighted to support Zentraxa on their journey to build scalable, sustainable biomaterials for health, industrial and personal uses. There are meaningful and wide-ranging applications for the innovative biomaterials that Zentraxa are creating. We look forward to seeing how Zentraxa progresses in the coming months.”

For more information, please visit www.zentraxa.com.

Recent News, Blogs and Stories

TECH XPO 2024

Tech-Xpo returns for 2025!

SETsquared Bristol’s flagship pitch, demo and connect showcase - Tech-Xpo - is back for 2025, and tickets are now open for you to attend. From trailblazing startups to game-changing scaleups,...
A headshot of the SETsquared Bristol Centre Manager, Caroline Thompson

Is your tech business ready for an incubator?

Caroline Thompson, SETsquared Bristol Centre Manager, reflects on what we look for when selecting new technology startups, and the questions to ask yourself before you apply to the incubator.   SETsquared Bristol has...
Three women sitting on chairs speaking at a panel event called Startup Stories: Spinout Edition

Startup Stories – Spinout Edition

The latest panel event in the Startup Stories series, Spinout Edition, saw two University of Bristol spinout leaders share their journeys—from academic labs to building businesses to short funding runways...

SUCCESS IS THE GOAL

Fast track your technology business